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In 2006, the Society for Adolescent
Medicine issued its second position paper
on HIV/AIDS in adolescents [1]. It noted
that although great progress had been
made in the scientific understanding,
diagnosis and treatment of HIV, and the
prevention of perinatal transmission, there
was a growing HIV crisis in the developing
world. At least half of all new infections in
the developing world were amongst youth
andyoung adults,and a substantialnumber
of teenagers and young adults were already
living with HIV/AIDS [2].
As HIV epidemics mature, increasing
numbers of children infected perinatally
survive and will present with HIV-related
symptoms in older childhood and adoles-
cence. Whilst the epidemiology of sexually
acquired HIV infection amongst 15–24
year olds is well described in southern
Africa [3–5], few data on the prevalence
and disease pattern of perinatally acquired
HIV infection in older children and
adolescence exist. Recent data from a
household survey conducted in South
Africa in 2008 estimated the prevalence
of HIV in children aged 2–14 years to
be 2.5% (95% confidence interval 1.9–3.5)
[6]. The survey indicates the relatively
high prevalence of HIV in children and
adolescents in this region. Most of these
infections are acquired early in life and are
probably undiagnosed.
The Survival of Infected
Children
Little is also known about the survival of
HIV-infected children in Africa beyond 5
years of age. Some studies have estimated
that 38% of children will be slow pro-
gressors and that the estimated cumulated
mortality at 15 years will be 83% [7].
Others estimate a 67% survival at 1 year,
39% at 5 years, and 13% survival at 10
years [8]. Decreased survival of HIV-
infected children in Africa to date is
attributed to lack of access to antiretroviral
therapy (ART), delayed diagnosis, and
inadequate management due to lack of
expertise and resources.
There are few data on the impact that
HIV has on ill-health, morbidity, and
mortality in adolescence in southern
Africa. A recent study modeled demo-
graphic, HIV prevalence, mother-to-child
transmission, and child survival data in
South Africa and Zimbabwe [9]. It esti-
mated that without treatment, the HIV
prevalence among 10 year olds in South
Africa will increase from 2.1% in 2008, to
3.3% in 2020, whereas in Zimbabwe it will
decrease from 3.2% in 2008 to 1.6% in
2020. Deaths among untreated slow pro-
gressors will increase in South Africa from
7,000peryearin2008to23,000peryearin
2030, and in Zimbabwe deaths will peak in
2014 at 9,700 per year, from 8,000 per year
in 2008. The toll of adolescent HIV on
other health outcomes such as hospital
admissions in these settings has yet to be
quantified.
A New Study on
Hospitalizations
In this issue of Plos Medicine, Ferrand
and colleagues present data on the causes
of acute hospitalization in adolescence
in Zimbabwe [10]. HIV has become the
single most common cause of acute ad-
mission and in-hospital death amongst
adolescents in Harare. Almost half of all
adolescents hospitalized were found to be
HIV infected, and most of them were
severely immunosuppressed, with the ma-
jor route of transmission being attributed
to perinatal transmission. Those admitted
were more likely to be stunted, have
pubertal delay, be a maternal orphan, or
have an HIV-infected mother as com-
pared to non-HIV admissions. Unlike
their HIV-negative counterparts, who
were largely admitted for trauma or an
acute exacerbation of a chronic medical
condition, HIV-infected adolescents were
more likely to be admitted for an infection
with tuberculosis, pneumonia, cryptococ-
cosis, and septicemia. HIV-infected ado-
lescents were also almost four times more
likely to die. The risk of in-hospital death
was increased in those HIV-infected
adolescents who had underlying chronic
complications.
These high rates of in-hospital mortality
are also seen in other parts of the region. A
study conducted in Zambia amongst HIV-
antibody positive children aged 1–14 years
found that a single hospitalization for a
severe bacterial infection increased the
risk of death by 42%, and a further
hospitalization doubled this risk again
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Linked Research Article
This Perspective discusses the fol-
lowing new study published in PLoS
Medicine:
Ferrand R, Bandason T, Musvaire, P,
L a r k eN ,N a t h o oK ,e ta l .( 2 0 1 0 )
Causes of Acute Hospitalization in
Adolescence: Burden and Spectrum
of HIV-Related Morbidity in a Country
with an Early-Onset and Severe HIV
Epidemic. PLoS Med 7(2): e1000178.
doi:10.1371/journal.pmed.1000178
PLoS Medicine | www.plosmedicine.org 1 February 2009 | Volume 7 | Issue 2 | e1000227[11]. Interventions to decrease HIV-relat-
ed deaths that occur in hospitals require
urgent investigation.
Diagnosis, Clinical
Manifestations, and Disease
Outcome
Older children and adolescents are
diagnosed late in Africa despite most
guardians suspecting their children of
being HIV infected before diagnosis [12].
The median age of diagnosis in some
studies has been found to be between 11–
12 years of age [10,12], with a delay of
3.5 years (interquartile range, 1–6 years)
between the first serious illness and
diagnosis of HIV infection. In addition,
when these adolescents are diagnosed,
they are already below average for height
and weight, have moderate to severe
immunodeficiency, and have had recur-
rent infections as well as tuberculosis.
Most of the hospital admissions for
HIV-infected adolescents in Harare in
Ferrand et al. ’s study were for infectious
diseases [10]. It is unclear whether any
data were collected on any underlying
depression or other concomitant mental
health diagnoses. Few data from southern
Africa are available on the psychological
manifestations, depressive symptoms, and
psychiatric admissions for children and
adolescents infected with HIV.
In contrast, studies from the developed
world show high rates of admissions for
psychiatric reasons amongst HIV-infected
children and adolescents. In the United
States, the PACTG 219C study—a pro-
spective cohort study designed to examine
long-term outcomes among HIV-infected
children and HIV-exposed uninfected
infants—found the incidence of psychiat-
ric admissions to be 6.17 cases per 1,000
person-years of follow-up, which was
significantly higher than that reported in
the general population (1.70 cases per
1,000 person-years) [13]. In this study, the
most common reasons for psychiatric
hospitalization for HIV-infected children
were for depression or behavioural disor-
ders. The median age for first psychiatric
admission was 11 years (range 4–17 years).
Knowledge of HIV status increased the
risk of hospital admissions 6-fold, and
having experienced a significant life event
increased the risk of hospitalization 3-fold.
Almost half of the admitted children
required multiple psychiatric admissions.
A previous study conducted amongst
HIV-infected adolescents in Harare shows
the tremendous burden HIV has on the
family [12]. More than half of the
adolescents participating in the study had
lost both parents, and chronic ill health
was reported in 44% of the surviving
parents. Almost half of the adolescents
were caring for sick parents, guardians,
and/or siblings. The impact of death and
chronic ill-health of a caregiver/and or
siblings on the mental health of HIV-
infected adolescents in southern Africa
requires further description.
Response to ART
Access to ART will improve health
outcomes and long-term survival of any
child that is infected early on in life,
irrespective of setting. In the developed
world, the long-term effects of protease-
inhibitor–based combination therapy have
shown greater improvements in CD4% in
younger children as compared to older
children. These findings may reflect great-
er thymic productivity in pre-adolescent
children than in adolescents and adults
[14] or other factors such as poorer
treatment adherence in older children.
Kekitiinwa and colleagues examined the
impact of ART across different geograph-
ical settings [15]. They looked at data
describing HIV and early growth responses
to ART across childhood, and compared
initial responses to ART in the United
Kingdom/Ireland and Uganda. They
found that although early mortality after
ART initiation was 3-fold higher in
Uganda as compared to the United King-
dom/Ireland, older children and adoles-
cents in Uganda had a superior virological
response to ART compared with those
from the United Kingdom/Ireland [15].
This difference was largely attributed to
successful adolescent support programs at
the Mulago Hospital in Kampala.
Additional data from Uganda, assessing
the impact of ART on growth and sexual
maturation in HIV-infected adolescents,
showed appropriate virological and im-
munological responses to ART, as well as
improvements in growth and to a much
lesser extent, sexual maturation [16]. In a
cohort of 118 perinatally infected, treat-
ment naı ¨ve 10–19 year olds, the effect of
antiretroviral was evaluated for a period of
12 months. At enrolment, the median
CD4 count was 124, which had increased
to 304 by 6 months, and to 370 by 12
months of treatment. ART was virologi-
cally suppressive in 79% of adolescents at
6 months, and by 89% at 12 months.
Disclosing HIV Diagnosis to
Adolescents
Disclosure issues abound both in the
developed and developing world. However,
studies suggest that there are medical
benefits to disclosure of HIV infection
status to children and adolescents. Children
and adolescents who know their HIV status
appear more likely to accept medical care
and have a higher self-esteem as compared
to youth that are unaware of their status
[17,18]. Nondisclosure can be associated
with anxiety and depression, in addition to
being excluded from social support. Reluc-
tance of parents and caregivers to disclose
the HIV status to a child or an adolescent is
usually based on the fear of discrimination
and stigma, towardboth the adolescent and
the family as a whole [19,20].
The American Academy of Pediatrics
strongly recommends the disclosure of HIV
status to adolescents [21], so that they are
fully informed about all aspects of their
health, including their sexual behaviour.
Ferrand and colleagues document a high
rate of disclosure amongst HIV-infected
adolescents in their study [10]. Neverthe-
less, they strongly recommend that health
professionals include adolescents in routine
provider-initiated testing and counseling,
and assist guardians with disclosure as a
way to improve early diagnosis and adher-
ence to subsequent ART.
Sexual Activity
Adolescents with moderate or severe
immunosuppression are less likely to have
adrenarche as compared to HIV-uninfect-
ed children of their own age [22].
However, the median age of sexual debut
of adolescents who acquired their infection
perinatally in southern Africa is unknown.
In a study conducted in the US, amongst
40 HIV-positive adolescents/young adults,
it was found that 28% of youth (mean age
of 16.6 years), reported being sexually
active [23]. When re-interviewed about 2
years later, 41% (mean age 18.3 years),
were sexually active. Other studies exam-
ining sexual behaviour of adolescents
infected with HIV as infants report
sexually activity ranging from 18% (mean
age of 15.5 years) [24], to 59% (mean age
18.5 years) in HIV-infected adolescents
with hemophilia who ever reported prior
sexual intercourse [25].
Of concern in these studies is that
although self-efficacy around condom use
was deemed to be high, it was not 100%
guaranteed [23]. In various studies, be-
tween 63% to 80% of perinatally infected
adolescents [24,25] reported using con-
doms. HIV knowledge of sexual transmis-
sion has been found to be low [23], and
these data highlight the need to provide
risk-reduction counseling to adolescents
who acquire HIV early in life.
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There is a substantial burden of HIV
infection in adolescents in southern Africa
who acquired HIV perinatally. It is
evident that they contribute substantially
to hospital admissions and in-hospital
deaths. There is an urgent need for
services that will be able to provide
accessible and appropriate HIV testing,
counseling, and support, as well as facili-
tate access to ART and appropriate sexual
risk-reduction interventions. The adoles-
cents admitted to hospitals in Harare
could have benefited from early diagnosis
and concomitant initiation of ART, and
this absence of treatment should not
continue to be the plight of similar
adolescents in our region.
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Box 1. Five Key Papers in the Field of Adolescent HIV
Ferrand RA, Banson T, Musvaire P, Larke N, Nathoo K, et al., 2010 [10].
This paper demonstrates the burden of HIV infection in adolescents who acquired
HIV infection in early life and how it contributes significantly to hospital
admissions and in-hospital mortality. The article also highlights the need for early
diagnosis, which will enable HIV-infected adolescents to benefit from earlier
access to treatment and care.
Shisana O, Rehle T, Simbayi LC, Zuma K, Jooste S, et al., 2009 [6]. This
report on a national household survey conducted in South Africa shows the
prevalence and incidence of HIV by age, gender, province, and geographic
locality. The report also assesses risk behaviour, such as condom use, multiple
concurrent partners, and sexual debut over time.
Ferrand RA, Corbett EL, Wood R, Hargrove J, Ndhlovu CE, et al., 2009
[9]. This paper models the time course and magnitude of the AIDS epidemic
among older children and adolescents in Southern Africa. These data are
important for health policy makers and economists who need to evaluate the
impact that the HIV epidemic has on health resources in Southern Africa.
Walker AS, Mulenga V, Sinyinza F, Lishimpi K, Nunn A, et al., 2006 [11].
This study evaluates the determinants of survival of HIV-infected children without
ART in Zambia. Data from this study demonstrates that malnutrition and
hospitalizations for respiratory or bacterial infections predict mortality indepen-
dent of immunosuppression.
Kekitiinwa A, Lee KJ, Walker AS, Maganda A, Doerholt K, et al., 2008
[15]. Few studies have directly compared responses to ART between children
living in resource-rich and resource-poor settings. This study showed that
irrespective of settings, overall immunological and virological responses to ART
were similar.
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